IP Library › Granted Patent US 11,883,601
Granted Patent B2
US 11,883,601 · App. 16/894,453 · Granted Jan 30, 2024

Nasal cannula

Inventors: Robert M. Landis (Mountainside, NJ); Charles A. Lewis (Carrabelle, FL); Louis Javier Collazo (Lauderdale by the Sea, FL)
A61M16/0672A61M16/0003A61M16/0666A61M16/0677A61M2016/1025A61M2205/18A61M2205/3331A61M2205/3368A61M2205/3379A61M2230/42A61M2230/432
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,883,601
App. No.
16/894,453
Granted
Jan 30, 2024
Kind
B2
Abstract

A gas delivery conduit adapted for fluidly connecting to a respiratory gases delivery system in a high flow therapy system. In one embodiment, a nasal cannula includes a base portion defining a first therapeutic gas passageway, a nozzle disposed adjacent said base portion and defining a second therapeutic gas passageway, the first passageway being in gaseous communication with the second passageway and a conduit configured to facilitate sensing that has an inlet side that is independent of and axially spaced apart from an outlet side of the nozzle. The conduit inlet side can extend beyond the nozzle outlet side of the nasal cannula. Additionally, the nasal cannula has a feature adapted to prevent one of the conduit and the nozzle from creating a seal with a user's nare and a feature adapted to prevent one of the conduit and the nozzle from creating a seal with a user's nare.

Claims (13)

1. A nasal cannula comprising:

a base portion defining a first therapeutic gas passageway;

a nasal insert disposed adjacent said base portion and defining a second therapeutic gas passageway, said first therapeutic gas passageway being in gaseous communication with said second therapeutic gas passageway;

at least one sensor for measuring the properties of gas adjacent said nasal insert, wherein the at least one sensor is disposed adjacent to or within said nasal insert;

an outlet formed in said base portion; and

an electrical wire that extends from the at least one sensor through said second therapeutic gas passageway and said outlet.

2. The nasal cannula of claim 1 , wherein said sensor comprises a pressure sensor.

3. The nasal cannula of claim 1 , wherein said sensor comprises a temperature sensor.

4. The nasal cannula of claim 1 , wherein said sensor comprises an oxygen sensor.

5. The nasal cannula of claim 1 , wherein said sensor comprises a gas flow rate sensor.

6. The nasal cannula of claim 1 , wherein said sensor comprises a carbon dioxide sensor.

7. An apparatus comprising the nasal cannula of claim 1 , further comprising a microprocessor, wherein the electrical wire connects the at least one sensor to the microprocessor, wherein the microprocessor is configured to control the flow of respiratory gases into the cannula and configured to use information received from the at least one sensor to control the flow of respiratory gases.

8. An apparatus comprising the nasal cannula of claim 1 , further comprising a microprocessor, wherein the electrical wire connects the at least one sensor to the microprocessor, wherein the microprocessor is configured to control the flow of respiratory gases into the cannula and the microprocessor is configured to use information received from the at least one sensor to issue an alarm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2021
From: MERGENET MEDICAL, INC.
To: RESMED PTY LTD
Reel/Frame 055573/0421 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2021
From: LANDIS, ROBERT M.; LEWIS, CHARLES A.; COLLAZO, LOUIS JAVIER
To: MERGENET MEDICAL, INC.
Reel/Frame 055656/0485 →
Continuity (4)
Continuation 14266659 · Apr 30, 2014
Continuation 11520490 · Sep 12, 2006
Provisional Application 60716776 · Sep 12, 2005
Related Publication 20200297961A1 · Sep 24, 2020